Food and Drug Administration (FDA)
Latest Recalls and Press Releases

September 16th, 2009 by viatheweb

Bitly url for this post: http://bit.ly/3rPc2

Latest FDA Recalls


Latest FDA Press Releases


  • FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers March 9, 2010
    The U.S. Food and Drug Administration today approved Botox (onabotulinumtoxin A) to treat spasticity in the flexor muscles of the elbow, wrist, and fingers in adults. Spasticity is common after stroke, traumatic brain injury, or the progression of multiple sclerosis.
  • FDA Update on the Investigation into the Salmonella Montevideo Outbreak - March 5, 2010 March 5, 2010
    As part of the Salmonella Montevideo investigation, the Food and Drug Administration has been actively investigating the supply chain of black and red pepper supplied to Daniele International Inc., Pascoag, R.I.
  • FDA Investigation Reveals Salmonella Tennessee at Plant that Makes Flavor Enhancers for Food Processors and Other Distributors March 4, 2010
    The U.S. Food and Drug Administration is actively investigating positive findings of Salmonella Tennessee in hydrolyzed vegetable protein (HVP) manufactured by Basic Food Flavors Inc. in Las Vegas, Nev. HVP is a flavor enhancer used in a wide variety of processed food products such as soups, sauces, chilis, stews, hot dogs, gravies, seasoned snack foods, dips and dressings. It is often blended with other spices to make seasonings that are used in or on foods. There are no reports of consumer illness associated with this recall. Only HVP manufactured by Basic Food Flavors is involved in this recall.
  • FDA Approves Name Change for Heartburn Drug Kapidex March 4, 2010
    The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex Change to Dexilant is part of FDA effort to prevent medication errors(dexlansoprazole) to avoid confusion with two other medications ? Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant.
  • March 3, 2010
    La Administracin de Medicamentos y Alimentos (FDA por sus siglas en ingls) est advirtiendo a los consumidores en Puerto Rico acerca de un alto contenido de la bacteria Burkholderia cepacia en los desinfectantes para manos: “Bee-Shield Hand Sanitizer? con Aloe Vera ( botellas de 10 onzas o de un galn) y ?MD Quality Hand Sanitizer? con Aloe Vera (botellas de 10 onzas). La bacteria Burkholderia cepacia puede causar infecciones graves en las personas.
  • FDA Warns Consumers in Puerto Rico of Harmful Bacteria in Hand Sanitizers March 3, 2010
    The U.S. Food and Drug Administration is warning consumers in Puerto Rico that two hand sanitizers ? “Bee-Shield Hand Sanitizer? with Aloe Vera (10 fl. oz. or 1 gallon bottles) and ?MD Quality Hand Sanitizer? with Aloe Vera (10 fl oz. bottles) ? contain high levels of a bacteria, Burkholderia cepacia, that can cause serious infections in humans.
  • FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs March 3, 2010
    The U.S. Food and Drug Administration, the Centers for Disease Control and Prevention and the U.S. Department of Agriculture?s Food Safety and Inspection Service (FSIS) will host a joint public workshop on how best to measure progress in reducing foodborne illnesses on March 30, in Washington, D.C.
  • FDA Calls on Food Companies to Correct Labeling Violations; FDA Commissioner Issues an Open Letter to the Industry March 3, 2010
    The U.S. Food and Drug Administration has notified 17 food manufacturers that the labeling for 22 of their food products violates the Federal Food, Drug, and Cosmetic Act.
  • FDA Survey Finds More Americans Read Information on Food Labels March 2, 2010
    A majority of consumers read food labels and are increasingly aware of the link between good nutrition and reducing the risk of disease, according to the latest survey of dietary habits released today by the U.S. Food and Drug Administration.
  • FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland March 2, 2010
    The U.S. Food and Drug Administration today approved the first generic version of Flomax Capsules 0.4 mg (tamsulosin hydrochloride) to treat benign prostatic hyperplasia (BPH), a condition in which an enlarged prostate gland causes problems with urination.




Click Here To Share This With A Friend!

Tags: , , , , , , , ,